Lupin debuts generic Truvada
Emtricitabine and tenofovir disoproxil fumarate tablets had a market value of $2.1 billion, according to March 2021 IQVIA data.
Lupin is introducing emtricitabine and tenofovir disoproxil fumarate tablets 200 mg/300 mg.
The product is the generic of Gilead’s Truvada.
The medication is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection. It also is used for pre-exposure prophylaxis to reduce the risk of sexually acquired HIV-1 infection.
Emtricitabine and tenofovir disoproxil fumarate tablets had a market value of $2.1 billion, according to March 2021 IQVIA data.